Search
Search Results
-
Lung Cancer A Comprehensive Guide for the Clinician
This book provides a comprehensive yet succinct update for the clinician in the diagnosis, staging, and treatment of lung cancer. Lung cancer is a...
-
Financial hardship experience in middle- and older-aged patients with advanced lung cancer
PurposeAdvancements in medical treatments have resulted in increased medical costs for cancer patients. More than half of the patients with advanced...
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
IntroductionRecent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the...
-
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
BackgroundCurrently, immunotherapy is widely used in the treatment of various stages of non-small cell lung cancer. According to clinical experience...
-
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia
Background and ObjectiveSince 2016, new therapies have transformed the standard of care for lung cancer, creating a need for up-to-date evidence for...
-
Significance of preoperative evaluation of modified advanced lung cancer inflammation index for patients with resectable non-small cell lung cancer
ObjectivesBody composition and systemic inflammation/nutrition have been identified as important clinical factors in cancer patients. The modified...
-
COVID-19 or Cancer Stress? Anxiety and Depressive Symptoms in Patients with Advanced Lung Cancer
BackgroundOf all cancer patients, those with lung cancer are among the highest risk for infection, pneumonia, hospitalization, and early death from...
-
Influence of malnutrition according to the glim criteria on the chemotherapy toxicities in patients with advanced lung cancer
BackgroundCancer-associated malnutrition is highly prevalent in advanced lung cancer, and 50% of global cancer-related deaths are attributed to...
-
A qualitative research exploring the experiences of patients receiving immune checkpoint inhibitors for advanced lung cancer
PurposesIn patients with advanced lung cancer, immune checkpoint inhibitors (ICIs) dramatically extended survival. We aimed to investigate the...
-
The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model
ObjectiveTo investigate the prognostic significance of the advanced lung cancer inflammation index (ALI) in patients with operable non-small-cell...
-
Optimizing double-layered convolutional neural networks for efficient lung cancer classification through hyperparameter optimization and advanced image pre-processing techniques
Lung cancer remains a leading cause of cancer-related mortality globally, with prognosis significantly dependent on early-stage detection....
-
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast
The identification of actionable biomarkers and development of targeted therapies have revolutionized the field of lung cancer treatment. In patients...
-
Examining the effects of physician burnout on pain management for patients with advanced lung cancer
PurposePhysician burnout is generally associated with worse clinical outcomes. The purpose of this study is to examine the effects of physician...
-
Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer
PurposeWe evaluated the surgical outcomes of salvage extended surgery after definitive medical treatment with an immune-checkpoint inhibitor (ICI)...
-
Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases
BackgroundTrastuzumab-based chemotherapy is a standard treatment regimen for human epithelial growth factor 2 (HER2)-positive gastric cancer. This is...
-
Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation
BackgroundInflammation and nutrition are important parameters that significantly affect survival in various malignancies. Prognostic nutritional...
-
Correlation of lung immune prognostic index with the efficacy of immune checkpoint inhibitors in Chinese patients with advanced non-small cell lung cancer
PurposeTreatment with immune checkpoint inhibitors (ICIs) improves the prognoses of patients with non-small cell lung cancer (NSCLC) but is...
-
The impact of social support on benefit finding among patients with advanced lung cancer and their caregivers: based on actor-partner interdependence mediation model
PurposeAdvanced lung cancer and its treatment serve as a sudden stressful event that profoundly impacts the psychological experience of both...
-
Lung Cancer Screening Practical Aspects for Primary Care
Lung cancer is the second most diagnosed cancer and remains the leading cause of cancer-related deaths in the United States. The high mortality is...
-
Distinct dyadic quality of life profiles among patient-caregiver dyads with advanced lung cancer: a latent profile analysis
PurposeThis study aimed to identify the heterogeneity of dyadic quality of life (QoL) profiles, determine whether these profiles differ in terms of...
